精品国产乱码一区,欧美自拍网站一二,亚洲AV熟女传媒一区二区三区,亚洲在线麻豆

咨詢熱線

15000266580

當前位置:首頁  >  技術文章  >  日本批準利用干細胞療法治療眼部疾病

日本批準利用干細胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3591

   日本研究人員獲得批準,可以開展利用干細胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導AMD患者身上取下的皮膚細胞使其處于一種類似于干細胞的狀態(tài)后再將其轉至患者,以達到治療效果。

干細胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細胞領域的研究獲得諾貝爾獎。

詳細英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網    管理登陸
强壮公让我夜夜高潮| 白浆| 人妻少妇久久中文字幕| 最新国产99热这里只有精品| 欧美a区| 素人阁久久久久精品人妻| 国产九色| 成人国产av精品| 欧美日韩国产一区二区| 大香蕉首页| 女同在线观看| 蜜桃狠狠狠狠狠狠狠狠狠| 国产一区二区不卡| 乱女伦露脸对白在线播放| 亚洲a级成人片在线观看| 国内精品无码一区二区三区| 亚洲成A人片在线观看日本| 在线欧美日韩制服国产| 亚洲av片不卡无码久久嫩模| 国产午夜福利片在线观看| 最近中文字幕国语免费高清6| 日本高清不卡中文字幕视频| 久久久综合亚洲色一区二区三区| 柳江县| 福州市| 中文字幕av中文字无码亚| 国产精品成人久久久久A伋| 久久综合婷婷丁香五月中文字幕 | 欧美人妖久久久aaa片| 激情97综合亚洲色婷婷五| 精品免费久久久久电影| 国产SUV精二区69| 色综合久久综合欧美综合网国产| 亚洲中文字幕在线观看| 少妇仑乱a毛片无码| 国产精品香港三级国产AV| 少妇爆乳一区二区三区中文无码| 天堂…在线最新版资源| 人妻少妇久久中文字幕一区二区| 久久人妻无码中文字幕第一| 亚洲一区二区三区高清在线观看|